PMC:7321036 / 44503-44725 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T170","span":{"begin":0,"end":222},"obj":"SO:0000855"}],"text":"or SARS-CoV-2 infection, kinase inhibitors were mapped to the most differentially regulated kinase activities (Figure 7 A) and to specific phosphorylation sites (Table S8; STAR Methods). This resulted in a list of 87 drugs"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T219","span":{"begin":3,"end":11},"obj":"Disease"},{"id":"T220","span":{"begin":14,"end":23},"obj":"Disease"},{"id":"T221","span":{"begin":172,"end":176},"obj":"Disease"}],"attributes":[{"id":"A219","pred":"mondo_id","subj":"T219","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A220","pred":"mondo_id","subj":"T220","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A221","pred":"mondo_id","subj":"T221","obj":"http://purl.obolibrary.org/obo/MONDO_0010408"}],"text":"or SARS-CoV-2 infection, kinase inhibitors were mapped to the most differentially regulated kinase activities (Figure 7 A) and to specific phosphorylation sites (Table S8; STAR Methods). This resulted in a list of 87 drugs"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T535","span":{"begin":99,"end":109},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T536","span":{"begin":120,"end":121},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T537","span":{"begin":204,"end":205},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"or SARS-CoV-2 infection, kinase inhibitors were mapped to the most differentially regulated kinase activities (Figure 7 A) and to specific phosphorylation sites (Table S8; STAR Methods). This resulted in a list of 87 drugs"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T300","span":{"begin":32,"end":42},"obj":"Chemical"},{"id":"T301","span":{"begin":168,"end":170},"obj":"Chemical"},{"id":"T302","span":{"begin":217,"end":222},"obj":"Chemical"}],"attributes":[{"id":"A300","pred":"chebi_id","subj":"T300","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A301","pred":"chebi_id","subj":"T301","obj":"http://purl.obolibrary.org/obo/CHEBI_29385"},{"id":"A302","pred":"chebi_id","subj":"T302","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"or SARS-CoV-2 infection, kinase inhibitors were mapped to the most differentially regulated kinase activities (Figure 7 A) and to specific phosphorylation sites (Table S8; STAR Methods). This resulted in a list of 87 drugs"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T321","span":{"begin":25,"end":42},"obj":"http://purl.obolibrary.org/obo/GO_0033673"},{"id":"T322","span":{"begin":92,"end":109},"obj":"http://purl.obolibrary.org/obo/GO_0016301"},{"id":"T323","span":{"begin":139,"end":154},"obj":"http://purl.obolibrary.org/obo/GO_0016310"}],"text":"or SARS-CoV-2 infection, kinase inhibitors were mapped to the most differentially regulated kinase activities (Figure 7 A) and to specific phosphorylation sites (Table S8; STAR Methods). This resulted in a list of 87 drugs"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1008","span":{"begin":3,"end":23},"obj":"Disease"}],"attributes":[{"id":"A1008","pred":"tao:has_database_id","subj":"1008","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"or SARS-CoV-2 infection, kinase inhibitors were mapped to the most differentially regulated kinase activities (Figure 7 A) and to specific phosphorylation sites (Table S8; STAR Methods). This resulted in a list of 87 drugs"}